A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic
- PMID: 32620220
- PMCID: PMC7212949
- DOI: 10.1016/j.amjms.2020.05.006
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic
Abstract
Since December 2019, the global pandemic caused by the highly infectious novel coronavirus 2019-nCoV (COVID-19) has been rapidly spreading. As of April 2020, the outbreak has spread to over 210 countries, with over 2,400,000 confirmed cases and over 170,000 deaths.1 COVID-19 causes a severe pneumonia characterized by fever, cough and shortness of breath. Similar coronavirus outbreaks have occurred in the past causing severe pneumonia like COVID-19, most recently, severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV). However, over time, SARS-CoV and MERS-CoV were shown to cause extrapulmonary signs and symptoms including hepatitis, acute renal failure, encephalitis, myositis and gastroenteritis. Similarly, sporadic reports of COVID-19 related extrapulmonary manifestations emerge. Unfortunately, there is no comprehensive summary of the multiorgan manifestations of COVID-19, making it difficult for clinicians to quickly educate themselves about this highly contagious and deadly pathogen. What is more, is that SARS-CoV and MERS-CoV are the closest humanity has come to combating something similar to COVID-19, however, there exists no comparison between the manifestations of any of these novel coronaviruses. In this review, we summarize the current knowledge of the manifestations of the novel coronaviruses SARS-CoV, MERS-CoV and COVID-19, with a particular focus on the latter, and highlight their differences and similarities.
Keywords: COVID-19; Middle east respiratory syndrome coronavirus; Novel coronavirus; Severe acute respiratory syndrome coronavirus.
Copyright © 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11. J Med Virol. 2020. PMID: 32104915 Free PMC article. Review.
-
Coronavirus Disease 2019: Coronaviruses and Blood Safety.Transfus Med Rev. 2020 Apr;34(2):75-80. doi: 10.1016/j.tmrv.2020.02.003. Epub 2020 Feb 21. Transfus Med Rev. 2020. PMID: 32107119 Free PMC article. Review.
-
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379. Eur Rev Med Pharmacol Sci. 2020. PMID: 32141570
-
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.Pediatr Pulmonol. 2020 Jul;55(7):1584-1591. doi: 10.1002/ppul.24810. Epub 2020 Jun 1. Pediatr Pulmonol. 2020. PMID: 32483934 Free PMC article. Review.
-
The novel zoonotic COVID-19 pandemic: An expected global health concern.J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671. J Infect Dev Ctries. 2020. PMID: 32235085
References
-
- University. JH: corona virus COVID-19 global cases. Centers for Systems Science and Engineering (CSSE)
-
- Zaki AM, van Boheemen S, Bestebroer TM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–1820. - PubMed
-
- Kupferschmidt K. Emerging diseases. Researchers scramble to understand camel connection to MERS. Science. 2013;341(6147):702. - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
-
Full Text Sources
-
Medical
-
Miscellaneous